Clinical Trials on Moderate to Severe Palmar Plantar Psoriasis
Total 292 results
-
Xinhua Hospital, Shanghai Jiao Tong University...TerminatedASD Accompanied by Moderate to Severe Gastrointestinal SymptomsChina
-
Merz North America, Inc.CompletedCorrection of Moderate to Severe Nasolabial Folds (NLFs)China
-
Merz North America, Inc.CompletedCorrection of the Moderate to Severe Nasolabial FoldsChina
-
Astellas Pharma Europe Ltd.CompletedModerate to Severe Vasomotor SymptomsUnited Kingdom
-
University of PadovaUnknownModerate to Severe Psoriasis. | Absolute Number, Density of Immune Infiltrate and Dendritic Cells and Inflammatory Cytokines Expression Pattern.Italy
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
Kyowa Kirin Co., Ltd.CompletedPsoriasis Vulgaris | Psoriatic Arthritis | Pustular; Psoriasis, Palmaris Et Plantaris | Psoriatic ErythrodermaJapan
-
Kyowa Kirin Co., Ltd.CompletedPsoriasis Vulgaris | Psoriatic Arthritis | Pustular; Psoriasis, Palmaris Et Plantaris | Psoriatic ErythrodermaJapan
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
Clin4allRecruitingPsoriasis of Scalp | Psoriasis Nail | Psoriasis Palmaris | Psoriasis Genital | Psoriasis PlantarisFrance
-
Lipidor ABRecruitingMild to Moderate PsoriasisIndia
-
Betta Pharmaceuticals Co., Ltd.Tigermed Consulting Co., LtdTerminatedMild to Moderate PsoriasisChina
-
BioMAS LtdWithdrawn
-
Kristian Reich, MDLEO PharmaCompletedMild to Moderate PsoriasisUnited Kingdom, Germany, France, Spain, Netherlands, Sweden, Italy, Denmark
-
Novartis PharmaceuticalsCompletedModerate and Severe Plaque PsoriasisUnited States, Argentina, Germany, Belgium, Italy, United Kingdom, Turkey, Guatemala, Australia
-
Tianjin Ever Union Biotechnology Co., Ltd.UnknownModerate and Severe Plaque PsoriasisChina
-
Etwal Ltd.CompletedMild to Moderate PsoriasisIsrael
-
UCB CelltechCompletedMild to Moderate PsoriasisUnited Kingdom
-
PfizerCompleted
-
Delenex Therapeutics AGCompletedMild-to-moderate Psoriasis VulgarisAustria, Germany
-
Shanghai Yueyang Integrated Medicine HospitalNot yet recruitingModerate-to-severe PsoriasisChina
-
Cadila PharnmaceuticalsLipidor AB, Svärdvägen 13 SE-182 33 Danderyd, SwedenCompleted
-
LG Life SciencesCompletedNormal, Healthy Adults With Moderate, Severe, or Very Severe Volume Loss of Anteromedial Malar Region Who Have Completed the LG-HACL014 StudyKorea, Republic of
-
Merz North America, Inc.CompletedCorrection of Moderate to Severe Nasolabial FoldsUnited States
-
QRxPharma Inc.CompletedAcute Moderate to Severe PainUnited States
-
Biocon Biologics Inc.MEDA Pharma GmbH & Co. KG; Mylan Inc.; IQVIA Pvt. LtdCompletedHulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and ImmunogenicityModerate Chronic Plaque Psoriasis | Severe Chronic Plaque PsoriasisBulgaria, Czechia, Estonia, Poland
-
Merck Sharp & Dohme LLCTerminatedWomen | Moderate to Severe Vasomotor Symptoms in Postmenopausal
-
Egalet LtdCompletedModerate-to-severe Chronic Noncancer PainUnited States
-
UCB Biopharma S.P.R.L.CompletedModerate and Severe Active Rheumatoid Arthritis | Active Psoriatic Arthritis | Active Ankylosing Spondylitis | Moderately to Severely Active Crohn's DiseaseUnited States
-
UCB Biopharma SRLRecruitingModerate Chronic Plaque Psoriasis | Severe Chronic Plaque Psoriasis | Mixed Guttate/Plaque PsoriasisUnited States, Canada, Puerto Rico
-
Novartis PharmaceuticalsActive, not recruitingPsoriatic Arthritis | Ankylosing Spondylitis | Moderate to Severe Plaque Psoriasis | Non-radiographic Axial SpondyloarthritisThailand
-
Janssen PharmaceuticaWithdrawnModerate to Severe Acute Non-Cancer Pain
-
Arxx TherapeuticsRecruitingHealthy Volunteers | Mild to Moderate PsoriasisUnited Kingdom
-
BioPharmX, Inc.CompletedModerate to Severe Papulopustular RosaceaUnited States
-
Janssen PharmaceuticaWithdrawnModerate to Severe Chronic Non-cancer Pain
-
KoBioLabsNovotech (Australia) Pty LimitedCompletedModerate to Severe AsthmaAustralia
-
AbbottCompletedModerate to Severe Chronic, Non-malignant PainUnited States
-
PfizerRecruitingActive Psoriatic Arthritis | Active Ankylosing Spondylitis | Active Moderate to Severe Rheumatoid ArthritisKorea, Republic of
-
Mundipharma Research GmbH & Co KGCompletedSubjects With Moderate to Severe, Chronic Nonmalignant Pain
-
Actavis Inc.CompletedModerate to Severe Papulopustular RosaceaUnited States
-
IpsenRecruitingModerate to Severe Upper Facial LinesGermany, France
-
Regeneron PharmaceuticalsSanofiCompletedModerate to Severe Atopic Hand and Foot DermatitisUnited States, Germany, Japan, Poland
-
Biosplice Therapeutics, Inc.CompletedModerate to Severe OsteoarthritisUnited States
-
NovartisCompletedModerate to Severe HypertensionRussian Federation, Romania, Singapore, Spain, Germany, Philippines
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingModerate to Severe Acne VulgarisChina
-
PollogenLumenis Be Ltd.RecruitingModerate to Severe Acne VulgarisUnited States
-
Nektar TherapeuticsTerminatedModerate to Severe Chronic PainUnited States
-
Boston PharmaceuticalsCompletedModerate to Severe Acne VulgarisUnited States, Canada
-
Mundipharma Research GmbH & Co KGCompletedModerate to Severe Idiopathic RLS With Daytime SymptomsSpain, Sweden, Germany
-
AcelRx Pharmaceuticals, Inc.CompletedModerate-to-severe Acute PainUnited States